Table 1.
Outcome | Groups | Sample size | Relative risk | 95% C.I. |
---|---|---|---|---|
Type-2 diabetes [48] | No napping | 9613 | Ref | |
Napping | 3851 | 1.30 | 1.01–1.69 | |
Respiratory disease [49•] | No napping | 7878 | Ref | |
Nap < 1 h | 2831 | 1.32 | 1.15–1.52 | |
Nap ≥ 1 h | 269 | 1.54 | 1.14–2.09 | |
Chronic lower respiratory disease [49•] | No napping | 7878 | Ref | |
Nap < 1 h | 2831 | 1.52 | 1.18–1.96 | |
Nap ≥ 1 h | 269 | 1.72 | 1.01–2.92 | |
All-cause mortality [47] | No napping | 11,493 | Ref | |
Nap < 1 h | 4412 | 1.14 | 1.02–1.27 | |
Nap ≥ 1 h | 469 | 1.32 | 1.04–1.68 |
aResults are expressed as relative risk (95% confidence intervals) between napping and reference category